Advertisement

Topics

FDA orphan status given to Celgene's pediatric ulcerative colitis drug

05:02 EST 19 Jan 2018 | SmartBrief

Celgene's Otezla, or apremilast, which is being developed as a treatment for pediatric patients with ulcerative colitis, was  -More

Original Article: FDA orphan status given to Celgene's pediatric ulcerative colitis drug

NEXT ARTICLE

More From BioPortfolio on "FDA orphan status given to Celgene's pediatric ulcerative colitis drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...